Abstract
The analytical chemists in process development in the pharmaceutical industry have to solve the difficult problem of producing high quality methods for purity determination and assay within a short time without a clear definition of the substance to be analyzed. Therefore the quality management is very difficult. The ideal situation would be that every method is validated before use. This is not possible because this would delay the development process. A process-type quality development approach with an estimation type fast validation (measurement uncertainty) is therefore suggested. The quality management process consists of the estimation of measurement uncertainty for early project status. Statistical process control (SPC) is started directly after measurement uncertainty estimation and a classical validation for the end of the project. By this approach a process is defined that allows a fast and cost-efficient way of supporting the development process with the appropriate quality at the end of the process and provides the transparency needed in the development process. The procedure presented tries to solve the problem of the parallelism between the two development processes (chemical and analytical development) by speeding up the analytical development process initially.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 25 March 1997 · Accepted: 17 May 1997
Rights and permissions
About this article
Cite this article
Küppers, S. A validation concept for purity determination and assay in the pharmaceutical industry using measurement uncertainty and statistical process control. Accred Qual Assur 2, 338–341 (1997). https://doi.org/10.1007/s007690050160
Issue Date:
DOI: https://doi.org/10.1007/s007690050160